Purdue Pharma

Pharmaceutical Manufacturing • Stamford, Connecticut, United States • 501-1000 Employees

Company overview

Headquarters	One Stamford Forum, 201 Tresser Blvd, Stamford, CT 06901, US
Phone number	+12035888000
Website	purduepharma.com
NAICS	3254
SIC	283
Keywords	Dietary Supplements, Pharmaceuticals, Sleep, Drug Development, Antiseptics, Laxatives, Prescription Opioids
Employees	501-1000
Socials

Key Contacts at Purdue Pharma

Kristen Brown

Associate Director, Talent Management & Strategic Hr Partner

Tom Morrissey

Senior Director Of Legal Operations & Ediscovery

John P. Gilbride

Director Ethics And Compliance

Bill Defrancesco

Director Of Health Systems

Diego Munoz

Associate Director Of Operations

Anu Raina

Director, Information Technology - Business Relationship Partner

Garth Whiteside

Executive Director

John Bredin

Associate Director Quality Assurance

Donstan Charles

Associate Director

Scott Denny

Associate Director Quality Assurance

Purdue Pharma Email Formats

Purdue Pharma uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@purduepharma.com), used 33.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@purduepharma.com	42.2%
{first initial}.{last name}	j.doe@pharma.com	42.2%
{2char}	{2char}@purduepharma.com	10.4%

About Purdue Pharma

Purdue Pharma’s bankruptcy case was heard before the Supreme Court of the United States in December 2023. In June 2024, the Court voted 5-4 against third-party releases contained in the Plan of Reorganization. The decision does nothing to deter us from the twin goals of using settlement dollars for opioid abatement and turning the company into an engine for good. We are reaching back out to creditors and renewing our pursuit of a resolution that delivers billions of dollars of value for opioid abatement and allows the Company to emerge from bankruptcy as a company with a public-minded mission. The Supreme Court’s decision does not affect Purdue’s operational stability or our ability to produce medications safely and effectively. We continue to operate fully, honoring our existing relationships and meeting our obligations to our partners and customers. The company will continue serving patients who rely on our medicines, and working to introduce new medicines that will help save and improve lives.

Purdue Pharma revenue & valuation

Annual revenue	$3,000,000,000
Revenue per employee	$3,283,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$9,600,000,000
Total funding	$1,800,000